Human Biospecimens, Primary Cells, and 3D Cancer Models
Every model starts with a real patient tumor, procured fresh with clinical metadata intact. Browse our inventory, check availability, and request a quote.
DRL US supplies pharmaceutical and biotech companies with human biospecimens, primary cell lines, and 3D cancer models for preclinical oncology research. Products include FFPE tissue samples, fresh and frozen tumor tissue, blood and biofluid specimens, low-passage primary cancer cells across 30+ tumor types, and patient-derived organoids and spheroids. All biospecimens are IRB-approved with full chain-of-custody documentation.
30K+
cancer types available
Low-passage · Patient-derived · Characterized
BIOBANK
Tumor cells, CAFs, TILs, normal fibroblasts. Low-passage, preserves tumor heterogeneity. 2D cultures, cryopreserved stocks, matched normal controls.
Tumor Cells
CAFs
TILs
Fibroblasts
Days
not months, like PDX
Organoids · Spheroids · Co-cultures
SERVICES
Patient-derived organoids replicating tumor architecture. Dose-response, combination studies, synergy analysis. Faster and cheaper than PDX.
Organoids
Spheroids
Co-culture
50K+
cases in biobank
33 hospitals - 18 clinics - 4 continents
EXPERTISE
FFPE, fresh, frozen tissue, blood, biofluids. Full clinical metadata and chain-of-custody with every sample. IRB-approved.
FFPE
Fresh
Frozen
Blood
BioFluids
TRending content
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
contact
28047 Dorothy Drive, #204, Agoura Hills, CA 91301, USA
